CEO Cheryl Maley spoke with Arron Aatkar, Healthcare Analyst at the Edison Group, about Starpharma’s dendrimer technology, the company’s partnerships, and its Star Navigator program. They also discuss Starpharma’s internal oncology programs, and upcoming key milestones and catalysts for investors to watch out for.